Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study

European Journal of Clinical Pharmacology
J U RosholmL F Gram

Abstract

The aim of the present study was to analyse the utilisation of antidepressants (ADs) and to compare the utilisation of the various ADs with special reference to duration of treatment courses. From the Odense Pharmacoepidemiologic Database (OPED), all users of and prescriptions for ADs in the County of Funen, Denmark (about 470,000 inhabitants), were identified for each year from 1992 to 1997 (6 years). Duration of treatment courses was calculated for the first incident period of continuous use of one AD and was compared for the various ADs using Kaplan-Meiers survival statistics with log rank tests. Continuous use was defined as use of a minimum of one tablet per day. Furthermore, the proportion of users presenting only one prescription was determined for each AD. In total, 37,598 patients presented 392,524 prescriptions during 1992-1997. The 1-year prevalence rose from 2.1% to 4.1% in 1997 and the incidence was 1.3% in 1997. The 1-year prevalence increased with age up to 16.5% in 1997 for patients aged 90 years or older. Citalopram was the most-used AD, but there were still a considerable number of patients commencing treatment with TCAs in 1997. Median duration of treatment courses was 196 days for TCAs versus 120 days for SS...Continue Reading

Citations

Jan 23, 2002·Pharmacoepidemiology and Drug Safety
Sep 28, 2004·European Journal of Clinical Pharmacology·Arcangelo CiunaCorrado Barbui
Oct 24, 2007·European Journal of Clinical Pharmacology·Agnès SoudryAnnick Alpérovitch
Aug 8, 2008·European Journal of Clinical Pharmacology·Kristina Johnell, Johan Fastbom
Nov 11, 2010·European Journal of Clinical Pharmacology·Karolina Andersson SundellMargda Waern
Jun 19, 2012·European Journal of Clinical Pharmacology·Gianluca TrifiròFabio Samani
Mar 16, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Laura AmodeoRiccardo Torta
Jul 9, 2005·Epidemiologia e psichiatria sociale·Matthew Hotopf, Corrado Barbui
Sep 29, 2011·European Journal of Public Health·Karolina Andersson SundellMika Gissler
Aug 2, 2013·European Journal of Clinical Pharmacology·Elisabetta PoluzziFabrizio De Ponti
Feb 25, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M W M van den BrandF de Vries
Jan 22, 2005·International Journal of Geriatric Psychiatry·Mauro PercudaniLorenzo Petrovich
Apr 8, 2004·Journal of Clinical Pharmacy and Therapeutics·P D KnoesterY A Hekster
Apr 14, 2006·Basic & Clinical Pharmacology & Toxicology·Jesper Hallas, Henrik Støvring
Oct 15, 2013·International Journal of Clinical Practice·K Andersson SundellS M Wallerstedt
Nov 24, 2004·Journal of Affective Disorders·Mauro PercudaniLorenzo Petrovich
Apr 10, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Annette Erlangsen, Yeates Conwell
Apr 17, 2015·Journal of Affective Disorders·Rob B K WandersPeter de Jonge
Jul 12, 2014·Journal of Affective Disorders·Donatella MarazzitiLiliana Dell'Osso
Mar 19, 2014·European Psychiatry : the Journal of the Association of European Psychiatrists·N AartsL E Visser
May 2, 2003·European Journal of Clinical Pharmacology·Dorte Gilså HansenJakob Kragstrup
Oct 21, 2011·American Journal of Hypertension·Ingrid M M van HaelstToine C G Egberts
Dec 23, 2015·Ciência & saúde coletiva·Adriano Roberto Tarifa VicenteAntônio Ignácio de Loyola Filho
Dec 17, 2009·The Australian and New Zealand Journal of Psychiatry·Daniel ExeterAmanda Wheeler
Apr 26, 2007·Pharmacoepidemiology and Drug Safety·Henrik Støvring
Jul 16, 2008·Journal of Clinical Psychopharmacology·James M BoltonWilliam D Leslie
Feb 25, 2010·Anesthesiology·Ingrid M M van HaelstWilton A van Klei
Nov 30, 2005·Pharmacoepidemiology and Drug Safety·Anthony GichangiWerner Vach
Jan 5, 2006·International Journal of Methods in Psychiatric Research·Corrado BarbuiUNKNOWN Psychotropic Drug Registry Study Group
Oct 15, 2019·Journal of Thrombosis and Haemostasis : JTH·David GaistAnton Pottegård
Nov 24, 2019·European Journal of Clinical Pharmacology·Laura PazzagliShahram Bahmanyar
May 11, 2011·Scandinavian Journal of Gastroenterology·Michael DallJesper Hallas
Dec 30, 2017·Pharmacoepidemiology and Drug Safety·Laura PazzagliShahram Bahmanyar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.